Genetic diversity among Lassa virus strains.

Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88

New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol (2002) 2.35

Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94

Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell (2015) 1.74

Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45

A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42

MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis (2006) 1.35

Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32

Pet rodents and fatal lymphocytic choriomeningitis in transplant patients. Emerg Infect Dis (2007) 1.31

Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30

Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis (2005) 1.28

Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27

Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever. Philos Trans R Soc Lond B Biol Sci (2012) 1.23

Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol (2009) 1.19

Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biol (2014) 1.16

Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol (2010) 1.15

Bear Canyon virus: an arenavirus naturally associated with the California mouse (Peromyscus californicus). Emerg Infect Dis (2002) 1.15

High diversity and ancient common ancestry of lymphocytic choriomeningitis virus. Emerg Infect Dis (2010) 1.14

A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13

Lassa fever, Nigeria, 2005-2008. Emerg Infect Dis (2010) 1.10

Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J (2008) 1.10

Identification of protective Lassa virus epitopes that are restricted by HLA-A2. J Virol (2006) 1.07

Enzootic transmission of yellow fever virus in Peru. Emerg Infect Dis (2003) 1.06

Novel arenavirus, Zambia. Emerg Infect Dis (2011) 1.06

Arenavirus variations due to host-specific adaptation. Viruses (2013) 0.99

Independent lineage of lymphocytic choriomeningitis virus in wood mice (Apodemus sylvaticus), Spain. Emerg Infect Dis (2009) 0.98

Genomic and phylogenetic characterization of Merino Walk virus, a novel arenavirus isolated in South Africa. J Gen Virol (2010) 0.97

Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever. PLoS Negl Trop Dis (2015) 0.96

A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. J Infect Dis (2013) 0.94

Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J Hum Virol (2001) 0.91

Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90

New Hosts of The Lassa Virus. Sci Rep (2016) 0.89

Two novel arenaviruses detected in pygmy mice, Ghana. Emerg Infect Dis (2013) 0.88

Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. Antiviral Res (2011) 0.88

Laboratory diagnosis of Lassa fever, liberia. Emerg Infect Dis (2010) 0.87

The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa. PLoS One (2012) 0.87

International external quality assessment study for molecular detection of Lassa virus. PLoS Negl Trop Dis (2015) 0.87

Host range and genetic diversity of arenaviruses in rodents, United Kingdom. Emerg Infect Dis (2008) 0.84

The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84

A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg (2013) 0.84

Sequence variability and geographic distribution of Lassa virus, Sierra Leone. Emerg Infect Dis (2015) 0.83

Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol (2015) 0.81

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl Trop Dis (2015) 0.80

Rapid and specific detection of Lassa virus by reverse transcription-PCR coupled with oligonucleotide array hybridization. J Clin Microbiol (2012) 0.80

Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers. J Vaccines Vaccin (2012) 0.79

Spatial and temporal evolution of Lassa virus in the natural host population in Upper Guinea. Sci Rep (2016) 0.78

Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification. Microbiol Immunol (2011) 0.78

Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa. Pharmacogenomics J (2016) 0.78

Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness. J Virol (2014) 0.77

Evidence of human infection by a new mammarenavirus endemic to Southeastern Asia. Elife (2016) 0.76

Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol (2015) 0.75

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation. MBio (2016) 0.75

Outbreak of lassa fever in Nigeria: measures for prevention and control. Pan Afr Med J (2016) 0.75

Comparison of MAGPIX®™ Assays and ELISA for the Detection of Hemorrhagic Fever Viruses. J Clin Microbiol (2016) 0.75

Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area. PLoS Negl Trop Dis (2017) 0.75

Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A (1992) 61.33

Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol (1985) 47.78

Evaluation of the maximum likelihood estimate of the evolutionary tree topologies from DNA sequence data, and the branching order in hominoidea. J Mol Evol (1989) 16.24

A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27

Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96

Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg (1970) 4.29

A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71

Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology (1988) 3.22

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21

Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol (1989) 2.79

Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36

Sequencing studies of pichinde arenavirus S RNA indicate a novel coding strategy, an ambisense viral S RNA. J Virol (1984) 2.13

The phylogeny of New World (Tacaribe complex) arenaviruses. Virology (1996) 2.11

Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. Virus Res (1985) 1.92

Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86

Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70

Molecular structure and early events in the replication of Tacaribe arenavirus S RNA. Virus Res (1987) 1.70

Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69

Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull World Health Organ (1975) 1.44

Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. Virology (1997) 1.44

Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol (1987) 1.40

Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela. Am J Trop Med Hyg (1999) 1.39

Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. Virus Res (1991) 1.37

Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology (1991) 1.35

Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35

The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. J Gen Virol (1997) 1.29

Surveillance of Lassa fever in missionaries stationed in West Africa. Bull World Health Organ (1975) 1.27

Molecular organization of Junin virus S RNA: complete nucleotide sequence, relationship with other members of the Arenaviridae and unusual secondary structures. J Gen Virol (1991) 1.27

Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology (1989) 1.25

Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24

Lassa fever: response to an imported case. N Engl J Med (1977) 1.23

Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17

Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg (1983) 1.16

Oliveros virus: a novel arenavirus from Argentina. Virology (1996) 1.15

Genetic characterization and phylogeny of Sabiá virus, an emergent pathogen in Brazil. Virology (1996) 1.10

The sequences of the N protein gene and intergenic region of the S RNA of pichinde arenavirus. Virology (1984) 1.08

Molecular systematics and paleobiogeography of the South American sigmodontine rodents. Mol Biol Evol (1998) 1.08

Sequence analysis of the small RNA segment of guinea pig-passaged Pichinde virus variants. Am J Trop Med Hyg (1999) 1.07

Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06

Arenavirus phylogeny: a new insight. Virus Genes (1998) 1.03

Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences. FEBS Lett (1990) 1.01

Molecular characterization of attenuated Junin virus strains. J Gen Virol (1997) 1.01

Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses. Virus Res (1997) 0.94

Genetic variation among Lassa and Lassa-related arenaviruses analysed by T1-oligonucleotide mapping. Ann Inst Pasteur Virol (1989) 0.90

Evolutionary biology of a Lassa virus complex. Med Microbiol Immunol (1986) 0.89

Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). Am J Trop Med Hyg (1996) 0.88

Computational characterisation of potential RNA-binding sites in arenavirus nucleocapsid proteins. Virus Genes (1996) 0.85

Sequence of the nucleocapsid protein gene of Machupo virus: close relationship with another South American pathogenic arenavirus, Junín. Arch Virol (1992) 0.83

Mastomys (rodentia: muridae) species distinguished by hemoglobin pattern differences. Am J Trop Med Hyg (1983) 0.80

[A patient with Lassa fever from the Upper Volta, diagnosed in the Netherlands]. Ned Tijdschr Geneeskd (1982) 0.79

Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11

Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32

Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02

Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72

Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59

Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14

Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28

Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03

ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92

Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg (1981) 3.72

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62

Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55

Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46

Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36

Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34

Immunization for Ebola virus infection. Nat Med (1998) 3.27

Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24

Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99

Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97

A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95

Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76

Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69

Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66

Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64

Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63

Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61

Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57

Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48

First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44

Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis (2007) 2.37

Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36

Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36

The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect (2001) 2.30

A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27